Clearside Biomedical Inc Sustainability Reports

Clearside Biomedical, Inc. is a biopharmaceutical company that develops and delivers treatments to restore and preserve vision for individuals with serious back-of-the-eye diseases. Its therapies primarily target the suprachoroidal space utilizing its proprietary SCS Microinjector platform.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900GQSUZO5HQ9DS29

4 reports from 2017 to 2024

• Clearside Biomedical Inc 2024 Form 10-K
• Clearside Biomedical Inc 2022 Annual Report on Form 10-K
• Clearside Biomedical Inc 2020 Annual Report
• Clearside Biomedical Inc 2017 Annual Report